Autopsy report · NCT01522092

Escitalopram in Anxiety Associated Chronic Obstructive Pulmonary Disease (COPD) Exacerbations

“Study was not given ethical approval- a alternative protocol required”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

Hull University Teaching Hospitals NHS Trust

Sponsor type

Government (non-US federal)

Conditions

Anxiety; COPD

Interventions

escitalopram

Participants

0

Sites

1

Countries

United Kingdom

Trials that died the same way

• Reflective Testing for Early Diagnosis of Pituitary Dysfunction
  “Study did not require ethics Approval as it was not considered research.” (74% match in meaning)
• Non-pharmacological Treatments in Migraine.
  “Due to the unavailability of the subjects who gave the consent to participate to the study protocol” (72% match in meaning)
• Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
  “Decision was made to not go forward with the study” (70% match in meaning)
• Opinions, Perceptions, & Thoughts of British Resident Doctors on Orthopaedics
  “Study did not progress past approvals” (68% match in meaning)
• To Compare the Efficacy of I.V 200 mg Iron Sucrose and 500 mg Iron Sucrose to Treat Anemia in Pregnancy
  “The investigators decided not to proceed with this study” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.